Impairment of nasal mucociliary clearance in former smokers with stable chronic obstructive pulmonary disease relates to the presence of a chronic bronchitis phenotype

Rhinology

Volumn 49, Issue 4, 2011, Pages 4-

  Koblizek, Vladimir ^a   Tomsova, Marketa ^a   Cermakova, Eva ^b   Papousek, Petr ^a   Pracharova, Sarka ^a   Mandalia, Rajiv A A ^a   Ceral, Jiri ^a   Novosad, Jakub ^b   Fila, Libor ^c   Sedlak, Vratislav ^a   Ruta, Jiri ^a   Bartos, Vladimir ^a   Salajka, Frantisek ^a   Hrnciarik, Michal ^a  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Ciliary frequency; COPD; Former smokers; Mucociliary clearance; Nasal epithelium

Indexed keywords

AGED; ARTICLE; BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CILIARY DYSKINESIA; EUKARYOTIC FLAGELLUM; FEMALE; GENETICS; HUMAN; LUNG FUNCTION TEST; MALE; MIDDLE AGED; MUCOCILIARY CLEARANCE; NOSE; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; SMOKING;

AGED; BRONCHITIS; CILIA; CILIARY MOTILITY DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUCOCILIARY CLEARANCE; NOSE; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SMOKING;

EID: 80053200337     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: 10.4193/Rhino11.051     Document Type: Article

References (50)

1. Caballero A, Torres-Duque CA, Jaramillo C, et al. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study). Chest. 2008; 133: 343-349.
2. MacNee W. Update in chronic obstructive pulmonary disease 2007. Am J Respir Crit Care Med. 2008; 177: 820-829.
3. Kim WJ, Hoffman E, Reilly J, et al. Association of COPD candidate genes with computed tomography emphysema and airway phenotypes in severe COPD. Eur Respir J. 2011; 37: 39-43.
4. Pistolesi M, Camiciottoli G, Paoletti M, et al. Identification of a predominant COPD phenotype in clinical practice. Respir Med. 2008; 102: 367-376.
5. Vestbo J, Prescott E, Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med. 1996; 153: 1530-1535.
6. Burgel PR, Nesme-Meyer P, Chanez P, et al. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest. 2009; 135: 975-982.
7. Prescott E, Lange P, Vestbo J. Chronic mucus hypersecretion in COPD and death from pulmonary infection. Eur Respir J. 1995; 8: 1333-1338.
8. Rogers DF. Airway Mucus Secretion. In: Barnes PJ, eds. Chronic Obstructive Pulmonary Disease, Cellular and Molecular Mechanisms. Boca Raton, FL: TaylorMMFrancis, 2005; 83-111.
9. Hasani A, Toms N, Agnew JE, et al. The effect of inhaled tiotropium bromide on lung mucociliary clearance in patients with COPD. Chest. 2004; 125: 1726-1734.
10. Rogers DF. Mucociliary dysfunction in COPD: effect of current pharmacotherapeutic options. Pulm Pharmacol Ther. 2005; 18: 1-8.
11. Bhowmik A, Chahal K, Austin G, Chakravorty I. Improving mucociliary clearance in chronic obstructive pulmonary disease. Respir Med. 2009; 103: 496-502.
12. Hattori M. Mucociliary function of chronic inflammation in upper and lower airways. Auris Nasus Larynx. 1994; 21: 219-225.
13. Montnémery P, Svensson C, Adelroth E, et al. Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema. Eur Respir J. 2001; 17: 596-603.
14. Roberts NJ, Lloyd-Owen SJ, Rapado F, et al. Relationship between chronic nasal and respiratory symptoms in patients with COPD. Respir Med. 2003; 97: 909-914.
15. Vachier I, Vignola AM, Chiappara G, et al. Inflammatory features of nasal mucosa in smokers with and without COPD. Thorax. 200422259: 303-307.
16. Hurst JR, Wilkinson TM, Perera WR, Donaldson GC, Wedzicha JA. Relationships among bacteria, upper airway, lower airway, and systemic inflammation in COPD. Chest. 2005; 127: 1219-1226.
17. Hurst JR, Perera WR, Wilkinson TM, Donaldson GC, Wedzicha JA. Systemic, upper and lower airway inflammation at exacerbation of COPD. Am J Respir Crit Care Med. 2006; 173: 71-78.
18. Hurst JR, Kuchai R, Michael P, et al. Nasal symptoms, airway obstruction and disease severity in chronic obstructive pulmonary disease. Clin Physiol Funct Imaging. 2006; 26: 251-256.
19. Sridhar S, Schembri F, Zeskind J, et al. Smoking-induced gene expression changes in the bronchial airway are reflected in nasal and buccal epithelium. BMC Genomics. 2008; 9: 259.
20. Escudier E, Le VT, Boucherat M, et al. Comparative frequencies of the beats of nasal and bronchial ciliary cells. Study in 10 adults without respiratory pathology. Rev Pneumol Clin. 1987; 43: 65-68.
21. Verra F, Fleury-Feith J, Boucherat M, et al. Do nasal ciliary changes reflect bronchial changes? An ultrastructural study. Am Rev Respir Dis. 1993; 147: 908-913.
22. Nihlén U, Montnémery P, Andersson M. Specific nasal symptoms and symptom-provoking factors may predict increased risk of developing COPD. Clin Physiol Funct Imaging. 2008; 28: 240-250.
23. Koblizek V, Dobesova T, Salajka F, et al. Examination of function and structure of respiratory cilia of adult patients suffering from chronic obstructive pulmonary disease-comparison of nasal and bronchial mucosa. Vnit Lek. 2009; 55: 1035-1042.
24. Piotrowska VM, Piotrowski WJ, Kurmanowska Z, et al. Rhinosinusitis in COPD: symptoms, mucosal changes, nasal lavage cells and eicosanoids. Int J Chron Obstruct Pulmon Dis. 2010; 5: 107-117.
25. Piatti G, Ambrosetii U, Santus P, Allegra L. Effects of salmeterol on cilia and mucus in COPD and pneumonia patients. Pharmacol Res. 2005; 51: 165-168.
26. Celli B, Cote C, Marin J, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004; 350: 1005-1012.
27. Puhan M, Garcia-Aymerich J, Frey M, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet. 2009; 374: 704-711.
28. Koblizek V, Salajka F, Cermakova E, et al. Relationship between quality of life and BODE index of stable ex-smokers with chronic obstructive pulmonary disease. Vnitr Lek. 2009; 55: 940-947.
29. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005; 26: 948-968.
30. Canciani M, Barlocco EG, Mastella G, et al. The saccharin method for testing mucociliary function in patients suspected of having primary ciliary dyskinesia. Pediatr Pulmonol. 1988; 5: 210-214.
31. Bush A, Chodhari R, Collins N, et al. Primary ciliary dyskinesia: current state of the art. Arch Dis Child. 2007; 92: 1136-1140.
32. Cordonnier C, Gilain L, Ricolfi F, et al. Acquired ciliary abnormalities of nasal mucosa in marrow recipients. Bone Marrow Transplant. 1996; 17: 611-616.
33. Ho JC, Chan KN, Hu WH et al. The effect of aging on nasal mucociliary clearance, beat frequency and ultrastructure of respiratory cilia. Am J Respir Crit Care Med. 2001; 163: 983-988.
34. Noone PG, Leigh MW, Sannuti A, et al. Primary ciliary dyskinesia: diagnostic and phenotypic features. Am J Respir Crit Care Med. 2004; 169: 459-467.
35. Santamaria F, de Santi MM, Grillo G, et al. Ciliary motility at light microscopy: a screening technique for ciliary defects. Acta Paediatrica. 1999; 88: 853-857.
36. Doran SA, Koss R, Tran CH, et al. Effect of serotonin on ciliary beating and intracellular calcium concentration in identified populations of embryonic ciliary cells. J Exp Biol. 2004; 207: 1415-1429.
37. Smith CM, Hirst RA, Bankart MJ, et al. Cooling of cilia allows functional analysis of beat pattern for diagnostic testing. Chest. 2011; 140: 186-190.
38. Chilvers MA, O'Callaghan C. Analysis of ciliary beat pattern and beat frequency using digital high speed imaging: comparison with the photomultiplier and photodiode methods. Thorax. 2000; 55: 314-317.
39. Chilvers MA, Rutman A, Callaghan CO. Functional analysis of cilia and ciliated epithelial ultrastructure in healthy children and young adults. Thorax. 2003; 58: 333-338.
40. Chilvers MA, McKean M, Rutman A, et al. The effects of coronavirus on human nasal ciliated respiratory epithelium. Eur Respir J. 200122218: 965-970.
41. Thomas B, Rutman A, ÓCallaghan C. Disrupted ciliated epithelium shows slower ciliary beat frequency and increased dyskinesia. Eur Respir J. 2009; 34: 401-404.
42. Robertson A, Stannard W, Passant C, ÓCallaghan C, Banerjee A. What effects does isoflurane have upon ciliary beat pattern: an in vivo study. Clin Otolaryngol. 2004; 29: 157-160.
43. Houtmeyers, E, Gosselink R, Gayan-Ramirez G, Decramer M. Regulation of mucociliary clearance in health and disease. Eur Respir J. 1999; 13: 1177-1188.
44. Agius AM, Smallman LA, Pahor AL. Age, smoking and nasal ciliary beat frequency. Clin Otolaryngol. 1998; 23: 227-230.
45. Jorissen M, Willems T, Van der Schueren B. Nasal ciliary beat frequency is age independent. Laryngoscope 1998; 108: 1042-1047.
46. Lappere TS, Sont JK, van Schadewijk A, et al. Smoking cessation and bronchial epithelial remodeling in COPD: a cross-sectional study. Respir Res. 2007; 8: 85.
47. Jorissen M. Correlations among mucociliary transport, ciliary function, and ciliary structure. Am J Rhinol. 1998; 12: 53-58.
48. Clary-Meinesz CF, Cosson J, Huitorel P, Blaive B. Temperature effect on the ciliary beat frequency of human nasal and tracheal ciliated cells. Biol Cell. 1992; 76: 335-338.
49. Clary-Meinesz CF, Mouroux J, Cosson J, Huitorel P, Blaive B. Influence of external pH on ciliary beat frequency in human bronchi and bronchioles. Eur Respir J. 1998; 11: 330-333.
50. Han MK, Agusti A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010; 182: 598-604.